Construction and Expression of Lentiviral Vector Plenti6/v5-S-k on SDF-KDEL
孙利,曲晓莉,张久聪,张颖,黄长形,连建奇,魏欣,姜泓,张野,庄严,翟嵩,孙永涛,聂青和,白雪帆
DOI: https://doi.org/10.3969/j.issn.1671-9638.2008.06.002
2008-01-01
Abstract:Objective To study the HIV-based lentiviral vector, pLenti6/V5-S-K, which contains the gene of interest , CXC-intrakine (SDF-KDEL), on the gene therapy of HIV-1 infection. Methods A pLenti-based expression vector, pLenti6/V5-D-TOPO, was used to produce the lentiviral vector, which was cotransfected with the ViraPower(superscript TM) Packaging Mix (pLP1, pLP2, and pLP/VSVG) into 293FT cells to produce a replication-incompetent lentivius stock. After lentiviral stock had been titrated the by HeLa cells, the expression of the interest gene of of SDF-1 could be assayed by indirect immunofluorescence in transduced HeLa cells. Results The lentiviral expression vector, pLenti6/V5-S-K, was confirmed by restriction enzyme digestion and sequencing. The lentivirus stock was constructed in 293 FT cell line. The fluorescent protein was mainly scattered in cytoplasm and perinucleus in transduced HeLa cells. Conclusion These findings demonstrated the ability of the lentiviral vector to transduce multiple genes into HeLa cells, and the potential therapeutic effect on the treatment of HIV-1 infection.